Rociletinib | Covalent Inhibitor of EGFR (Mutant:L858R/T790M)
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
EGFR (Mutant:L858R/T790M)
  • Ki:21.5 nM L858R/T790M; 303.3 nM WT
  • IC50:62-187 nM
Covalent Inhibitor
100 - 1000 nM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
Rociletinib selectivity was tested against 434 kinases in duplicate at a concentration of 0.1μM a ...

Potency
Cellular
In Vitro

EGFR (Mutant:L858R/T790M)

Mode of Action: Covalent Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1158/1535-7163.MCT-13-0966

In Vivo Validations

Mouse
Dose: 3-100 mg/Kg
Route of delivery: Oral
Plasma half life: 2.6 h

DOI Reference: 10.1158/1535-7163.MCT-13-0966

Orthogonal Probes def

WZ4002

Chemical Information

Molecular Formula C27H28F3N7O3
SMILEs C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1
InChI InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)
Molecular weight 555.22 Da
AlogP 4.7842
HBond acceptors 10
HBond donors 3
Atoms 68

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for Rociletinib

Probe Rociletinib is in the process of SERP review.

Please continue to check back for new reviews and commentary.